Dr. Peter Attia

The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest very seriously.

The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest very seriously.

For all of my disclosures and the companies I invest in or advise, please visit peteratiamd.com forward slash about where I keep an up-to-date and active list of all disclosures.

For all of my disclosures and the companies I invest in or advise, please visit peteratiamd.com forward slash about where I keep an up-to-date and active list of all disclosures.

Hey everyone, welcome to The Drive Podcast. I'm your host, Peter Attia. This podcast, my website, and my weekly newsletter all focus on the goal of translating the science of longevity into something accessible for everyone. Our goal is to provide the best content in health and wellness, and we've established a great team of analysts to make this happen.

Hey everyone, welcome to The Drive Podcast. I'm your host, Peter Attia. This podcast, my website, and my weekly newsletter all focus on the goal of translating the science of longevity into something accessible for everyone. Our goal is to provide the best content in health and wellness, and we've established a great team of analysts to make this happen.

It is extremely important to me to provide all of this content without relying on paid ads. To do this, our work is made entirely possible by our members, and in return, we offer exclusive member-only content and benefits above and beyond what is available for free.

It is extremely important to me to provide all of this content without relying on paid ads. To do this, our work is made entirely possible by our members, and in return, we offer exclusive member-only content and benefits above and beyond what is available for free.

If you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of a subscription. If you want to learn more about the benefits of our premium membership, head over to peteratiamd.com forward slash subscribe. My guest this week is Dr. Susan Desmond-Hellman.

If you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of a subscription. If you want to learn more about the benefits of our premium membership, head over to peteratiamd.com forward slash subscribe. My guest this week is Dr. Susan Desmond-Hellman.

Sue is a physician who is board certified in internal medicine and medical oncology. Her impressive career has spanned multiple fields. She has been a leader in the pharmaceutical industry where she helped develop several groundbreaking drugs, worked as the chancellor of the health science campus of a major university system, UCSF, and served as the CEO of the Bill and Melinda Gates Foundation.

Sue is a physician who is board certified in internal medicine and medical oncology. Her impressive career has spanned multiple fields. She has been a leader in the pharmaceutical industry where she helped develop several groundbreaking drugs, worked as the chancellor of the health science campus of a major university system, UCSF, and served as the CEO of the Bill and Melinda Gates Foundation.

She also served on numerous boards of both corporations and nonprofit organizations and She co-chaired the National Academy of Science Committee that pioneered precision medicine and currently sits on the board of OpenAI.

She also served on numerous boards of both corporations and nonprofit organizations and She co-chaired the National Academy of Science Committee that pioneered precision medicine and currently sits on the board of OpenAI.

I wanted to have Sue on this podcast to speak about her extraordinary career spanning medicine, oncology, biotech, and global health leadership, and to really explore her knowledge on how scientific innovation and leadership can drive better healthcare outcomes.

I wanted to have Sue on this podcast to speak about her extraordinary career spanning medicine, oncology, biotech, and global health leadership, and to really explore her knowledge on how scientific innovation and leadership can drive better healthcare outcomes.

In this episode, we discuss her early days in medicine, training at UCSF during the start of the AIDS crisis before people even knew what it was, and the lessons that she learned on handling uncertainty, balancing public health messaging, and accelerating treatment breakthroughs.

In this episode, we discuss her early days in medicine, training at UCSF during the start of the AIDS crisis before people even knew what it was, and the lessons that she learned on handling uncertainty, balancing public health messaging, and accelerating treatment breakthroughs.

The decision that she made to specialize in oncology and how her time treating HIV-related cancers in Uganda reinforced the need for integrating epidemiology patient care and policy to combat global health crises. We spoke about her transition into biotech, helping develop breakthrough cancer drugs like Taxol, Herceptin, and Avastin, and the role of precision medicine in improving outcomes.

The decision that she made to specialize in oncology and how her time treating HIV-related cancers in Uganda reinforced the need for integrating epidemiology patient care and policy to combat global health crises. We spoke about her transition into biotech, helping develop breakthrough cancer drugs like Taxol, Herceptin, and Avastin, and the role of precision medicine in improving outcomes.